Trademark: 90056955
Word

Status
Dead
Status Code
602
Status Date
Friday, September 10, 2021
Serial Number
90056955
Mark Type
2000
Filing Date
Thursday, July 16, 2020
Abandoned Date
Tuesday, July 27, 2021

Trademark Owner History

Classifications
5 Pharmaceutical preparations for the treatment of immunological, viral, inflammatory, infectious autoimmune disorders; Pharmaceutical preparations for the treatment and prevention of COVID-19 (SARSCOV-2) and coronavirus; Pharmaceutical preparations and substances, used internally as liquid medicines syrup, emulsion or suspension or solids as pills or capsules or chewable tablets for the treatment and prevention of viral infections by boosting the immune system to kill viruses, bacteria, coronaviruses including COVID-19 (SARS-COV-2) and coronavirus; Pharmaceutical preparations for the prevention of COVID-19 (SARS-COV-2) and coronavirus; Pharmaceutical preparations for the treatment and prevention of COVID-19 (SARSCOV-2) and coronavirus; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of COVID-19 (SARS-COV-2) and coronavirus; Pharmaceutical preparations for COVID-19 (SARSCOV-2) and coronavirus; Pharmaceutical preparations, namely, elixirs for the treatment of COVID-19 (SARS-COV-2) and coronavirus; Pharmaceutical products for treating respiratory diseases; Chemical preparations for pharmaceutical or medical purposes, namely, for COVID-19 (SARS-COV-2) and coronavirus; Inhaled pharmaceutical preparations for the treatment of COVID-19 or coronavirus respiratory diseases and disorders; Therapeutic pharmaceutical for the treatment of COVID-19 (SARS-COV-2) and coronavirus; Pharmaceutical preparations to boost, enhance, induce, or train and educate the immune system for the treatment of COVID-19 disease and immune system related diseases and disorders Dietary and nutritional supplements for therapeutic treatment to boost immune system responses against COVID-19 disease and immune related diseases and disorders; Dietary and nutritional supplements for boosting immune system responses; Pharmaceuticals, namely, immunomodulators, antivirals, antibiotics and anti-inflammatories
44 Dispensing of pharmaceuticals; Providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; pharmaceutical advice
The color(s) white, gray, black, blue, light blue and dark blue is/are claimed as a feature of the mark.
The mark consists of a shield having overlapping colors of blue, light blue and dark blue, the shield having an outer border with colors ranging from white to gray to black.

Trademark Events
Sep 10, 2021
Abandonment Notice E-Mailed - Failure To Respond
Sep 10, 2021
Abandonment - Failure To Respond Or Late Response
Jan 26, 2021
Notification Of Non-Final Action E-Mailed
Jan 26, 2021
Non-Final Action E-Mailed
Jan 26, 2021
Non-Final Action Written
Jan 25, 2021
Assigned To Examiner
Dec 1, 2020
Assigned To Examiner
Nov 4, 2020
Assigned To Examiner
Oct 29, 2020
Assigned To Examiner
Oct 28, 2020
Assigned To Examiner
Aug 14, 2020
Notice Of Design Search Code E-Mailed
Aug 13, 2020
New Application Office Supplied Data Entered In Tram
Jul 20, 2020
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24